rs116862713 — PRKAB1

Rare AMPK beta-1 subunit variant linking central energy sensing to shared migraine and type 2 diabetes susceptibility

See your personal result for PRKAB1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Central Energy Sensor at the Crossroads of Migraine and Metabolism

PRKAB1 encodes the beta-1 regulatory subunit of AMP-activated protein kinase (AMPK)11 AMP-activated protein kinase (AMPK)
AMPK is a heterotrimeric enzyme complex that acts as the cell's master energy sensor, activated when cellular energy (ATP) drops and AMP rises, the cell's master fuel gauge. AMPK monitors the ratio of AMP to ATP in every cell and triggers metabolic adaptations when energy is scarce: switching on glucose uptake, fatty acid oxidation, and mitochondrial biogenesis while shutting down energy-consuming processes. The rs116862713 variant lies in the regulatory region near PRKAB1 on chromosome 12q24.23 and was identified as a novel shared locus between migraine and type 2 diabetes.

The Mechanism

The AMPK beta-1 subunit serves as a scaffold that holds the catalytic alpha subunit and regulatory gamma subunit together, and it contains a carbohydrate-binding module (CBM) that allows AMPK to sense glycogen stores directly. The beta-1 subunit also contains the autophosphorylation site (Ser108) required for activation by certain upstream kinases and small-molecule activators including metformin's downstream effectors. 22 AMPK exists as alpha-beta-gamma heterotrimers. The beta subunit determines subcellular localization and substrate specificity

The rs116862713 T allele, located near PRKAB1, may alter AMPK beta-1 expression or regulation, affecting cellular energy sensing. This has two key consequences: (1) impaired AMPK-mediated glucose uptake and insulin sensitization relevant to type 2 diabetes, and (2) altered neuronal energy metabolism and microglial polarization relevant to migraine. In the brain, AMPK activation shifts microglia toward a reparative phenotype and dampens central sensitization, a key process in migraine chronification.

The Evidence

The cross-trait GWAS33 cross-trait GWAS
Siewert-Rocks et al. Genetic Overlap Analysis Identifies a Shared Etiology between Migraine and Headache with Type 2 Diabetes. Genes, 2022 identified rs116862713 at the PRKAB1 locus as one of 23 novel shared loci between migraine and T2D (P = 1.01 x 10-8), with concordant risk effects (migraine OR 1.06, T2D OR 1.08 for the T allele). This represents the largest per-allele effect among the four shared loci studied from this analysis, though the variant is rare (~2.6% in Europeans, <1% in East Asians and Africans).

A large-scale genetic association study44 large-scale genetic association study
Sun et al. Haplotype structures and large-scale association testing of AMPK genes with type 2 diabetes. Diabetes, 2006 examined common PRKAB1 variants in 4,206 individuals but did not find significant associations with T2D for common variants, suggesting that rare variants like rs116862713 may have stronger individual effects.

AMPK's role as a central energy sensor is well-established. It mediates the glucose-lowering effects of metformin55 metformin
Hardie DG. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol, 2012, the most widely prescribed diabetes drug, and responds to exercise, caloric restriction, and various nutritional signals.

Practical Actions

This is a rare variant with a relatively strong per-allele effect on both migraine and metabolic risk. Carriers may benefit from AMPK- activating strategies including specific supplements and monitoring of metformin response if prescribed. The variant's rarity means clinical data is limited, and evidence should be considered preliminary.

Interactions

AMPK signaling intersects with virtually every metabolic pathway in the cell. Carriers who also have TCF7L2 risk alleles (rs7903146) face compounding diabetes risk through convergent but independent mechanisms: TCF7L2 affects beta-cell insulin secretion while PRKAB1 affects peripheral insulin sensitivity. The AMPK pathway also intersects with the mTOR, SIRT1, and PGC-1alpha networks that regulate mitochondrial function and aging.

Drug Interactions

metformin dose_adjustment literature

Nutrient Interactions

alpha-lipoic acid increased_need

Genotype Interpretations

What each possible genotype means for this variant.

CC Normal AMPK Function Normal

Standard AMPK energy sensing with typical metabolic regulation

You carry two copies of the common C allele near the PRKAB1 gene. Your AMPK energy-sensing pathway functions at baseline levels, supporting normal glucose uptake, fatty acid oxidation, and metabolic adaptation to energy demands. About 97% of the global population shares this genotype.

CT Altered Energy Sensing Intermediate

One copy of the rare variant modestly impairs AMPK energy sensing

The T allele at rs116862713 was identified in cross-trait GWAS as a shared risk variant for migraine and type 2 diabetes (P = 1.01 x 10-8). PRKAB1 encodes the beta-1 regulatory subunit of AMPK, which mediates cellular energy sensing, glucose uptake, and fatty acid oxidation. Altered AMPK function can impair cellular adaptation to energy stress, contributing to insulin resistance and altered neuronal energy metabolism relevant to migraine. The variant is rare but has a notably larger effect size than common shared loci, consistent with the pattern that rare variants tend to have stronger individual effects. As this is a novel cross-trait GWAS finding, the evidence level is preliminary.

TT Impaired Energy Sensing High Risk

Extremely rare — two copies may significantly alter AMPK function and metabolic adaptation

Homozygous TT at rs116862713 is exceptionally rare. AMPK is a heterotrimer whose beta-1 subunit (encoded by PRKAB1) serves as the structural scaffold and contains a glycogen-sensing domain. With two copies of the risk allele, AMPK complex assembly or activation may be more meaningfully altered, potentially impairing glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and the cellular response to metformin. In the brain, AMPK normally dampens central sensitization by promoting anti-inflammatory microglial polarization; impaired AMPK function may lower the threshold for migraine. The extreme rarity of this genotype means no direct clinical studies exist, and all recommendations are extrapolated from AMPK biology and the cross-trait GWAS signal. Evidence should be considered preliminary.